Literature DB >> 23024097

Assessment of potential bias from non-participation in a dynamic clinical cohort of long-term childhood cancer survivors: results from the St. Jude Lifetime Cohort Study.

Rohit P Ojha1, S Cristina Oancea, Kirsten K Ness, Jennifer Q Lanctot, D Kumar Srivastava, Leslie L Robison, Melissa M Hudson, James G Gurney.   

Abstract

BACKGROUND: To evaluate long-term health outcomes among childhood cancer survivors, St. Jude Children's Research Hospital (SJCRH) has established the St. Jude Lifetime Cohort Study (SJLIFE), comprised of adult survivors who undergo risk-directed clinical assessments. As in any human research study, SJLIFE participants are volunteers who may not represent the source population from which they were recruited. A lack of proportional representation could result in biased estimates of exposure-outcome associations. We compared available demographic, disease, and neighborhood level characteristics between participants and the source population to assess the potential for selection bias. PROCEDURES: Potentially eligible patients for SJLIFE were enumerated as of October 31, 2011. Data from electronic medical records were combined with geocoded census data to develop an analytic data set of 3,108 patients (the evaluable source population) of whom 1,766 (57%) underwent clinical assessment (participants). The ratio of relative frequencies (RRFs) for characteristics was compared between participants and the source population, where RRF = 1.0 indicates equal frequency of the characteristic.
RESULTS: Participants and the source population had similar frequencies for most characteristics. Characteristics with modest relative differences (RRFs between 0.86 and 1.11) included sex, distance from SJCRH, primary diagnosis, median household income, median home value, and urbanicity.
CONCLUSIONS: Our results indicate a lack of substantive differences in the relative frequencies of demographic, disease, or neighborhood characteristics between participants and the source population in SJLIFE, thus alleviating serious concerns about selective non-participation in this cohort. Bias in specific exposure-outcome relations is still possible and will be considered in individual analyses.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23024097      PMCID: PMC3548083          DOI: 10.1002/pbc.24348

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

1.  Non-response and related factors in a nation-wide health survey.

Authors:  K Korkeila; S Suominen; J Ahvenainen; A Ojanlatva; P Rautava; H Helenius; M Koskenvuo
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

3.  Rural definitions for health policy and research.

Authors:  L Gary Hart; Eric H Larson; Denise M Lishner
Journal:  Am J Public Health       Date:  2005-07       Impact factor: 9.308

4.  The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  E Shahar; A R Folsom; R Jackson
Journal:  Ann Epidemiol       Date:  1996-11       Impact factor: 3.797

5.  Response and follow-up bias in cohort studies.

Authors:  S Greenland
Journal:  Am J Epidemiol       Date:  1977-09       Impact factor: 4.897

6.  Childhood cancer occurrence in relation to power line configurations: a study of potential selection bias in case-control studies.

Authors:  J G Gurney; S Davis; S M Schwartz; B A Mueller; W T Kaune; R G Stevens
Journal:  Epidemiology       Date:  1995-01       Impact factor: 4.822

7.  Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.

Authors:  Wendy Landier; Smita Bhatia; Debra A Eshelman; Katherine J Forte; Teresa Sweeney; Allison L Hester; Joan Darling; F Daniel Armstrong; Julie Blatt; Louis S Constine; Carolyn R Freeman; Debra L Friedman; Daniel M Green; Neyssa Marina; Anna T Meadows; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Kathleen S Ruccione; Charles A Sklar; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2004-12-02       Impact factor: 44.544

8.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

9.  Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg.

Authors:  Ala'a Alkerwi; Nicolas Sauvageot; Sophie Couffignal; Adelin Albert; Marie-Lise Lair; Michèle Guillaume
Journal:  BMC Med Res Methodol       Date:  2010-09-07       Impact factor: 4.615

10.  Practical matters, rather than lack of trust, motivate non-participation in a long-term cohort trial.

Authors:  Gert Helgesson; Mats G Hansson; Johnny Ludvigsson; Ulrica Swartling
Journal:  Pediatr Diabetes       Date:  2009-02-27       Impact factor: 4.866

View more
  59 in total

1.  Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).

Authors:  Daniel M Green; Liang Zhu; Mingjuan Wang; Kirsten K Ness; Matthew J Krasin; Nickhill H Bhakta; M Beth McCarville; Saumini Srinivasan; Dennis C Stokes; DeoKumar Srivastava; Rohit Ojha; Kyla Shelton; Ching-Hon Pui; Gregory T Armstrong; Daniel A Mulrooney; Monika Metzger; Sheri L Spunt; Fariba Navid; Andrew M Davidoff; Bhaskar N Rao; Leslie L Robison; Melissa M Hudson
Journal:  Ann Am Thorac Soc       Date:  2016-09

2.  Breastfeeding practices among childhood cancer survivors.

Authors:  Susan Ogg; James L Klosky; Wassim Chemaitilly; Deo Kumar Srivastava; Mingjuan Wang; Ginger Carney; Rohit Ojha; Leslie L Robison; Cheryl L Cox; Melissa M Hudson
Journal:  J Cancer Surviv       Date:  2020-04-14       Impact factor: 4.442

3.  Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.

Authors:  J G Gurney; S C Kaste; W Liu; D K Srivastava; W Chemaitilly; K K Ness; J Q Lanctot; R P Ojha; K A Nottage; C L Wilson; Z Li; L L Robison; M M Hudson
Journal:  Pediatr Blood Cancer       Date:  2014-02-28       Impact factor: 3.167

4.  Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study.

Authors:  Israel Fernandez-Pineda; Andrew M Davidoff; Lu Lu; Bhaskar N Rao; Carmen L Wilson; D Kumar Srivastava; James L Klosky; Monica L Metzger; Matthew J Krasin; Kirsten K Ness; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Charles A Sklar; Daniel M Green; Wassim Chemaitilly
Journal:  Pediatr Blood Cancer       Date:  2018-05-11       Impact factor: 3.167

5.  Patterns of Loss to Follow-Up Care Among Childhood Cancer Survivors.

Authors:  Denise A Rokitka; Colleen Curtin; Jennifer E Heffler; Michael A Zevon; Kris Attwood; Martin C Mahoney
Journal:  J Adolesc Young Adult Oncol       Date:  2016-08-16       Impact factor: 2.223

6.  Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy.

Authors:  Gregory T Armstrong; Wilburn E Reddick; Ronald C Petersen; Aimee Santucci; Nan Zhang; Deokumar Srivastava; Robert J Ogg; Claudia M Hillenbrand; Noah Sabin; Matthew J Krasin; Larry Kun; Ching-Hon Pui; Melissa M Hudson; Leslie L Robison; Kevin R Krull
Journal:  J Natl Cancer Inst       Date:  2013-04-12       Impact factor: 13.506

7.  Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study.

Authors:  S Cristina Oancea; James G Gurney; Kirsten K Ness; Rohit P Ojha; Vida L Tyc; James L Klosky; DeoKumar Srivastava; Dennis C Stokes; Leslie L Robison; Melissa M Hudson; Daniel M Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-17       Impact factor: 4.254

8.  Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.

Authors:  Kirsten K Ness; Kendra E Jones; Webb A Smith; Sheri L Spunt; Carmen L Wilson; Gregory T Armstrong; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; James G Gurney
Journal:  Arch Phys Med Rehabil       Date:  2013-03-26       Impact factor: 3.966

9.  Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.

Authors:  Kerri A Nottage; Kirsten K Ness; Chenghong Li; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Br J Haematol       Date:  2014-01-27       Impact factor: 6.998

10.  Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.

Authors:  Tara M Brinkman; Johnnie K Bass; Zhenghong Li; Kirsten K Ness; Amar Gajjar; Alberto S Pappo; Gregory T Armstrong; Thomas E Merchant; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; James G Gurney
Journal:  Cancer       Date:  2015-08-19       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.